References
- Hekking PP, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The
prevalence of severe refractory asthma. J Allergy Clin Immunol .
2015;135:896-902.
- Vianello A, Caminati M, Andretta M, et al. Prevalence of severe asthma
according to the drug regulatory agency perspective: an Italian
experience. World Allergy Organ J. 2019;12:100032.
- Chhiba KD, Patel GB, Vu THT, et al. Prevalence and characterization of
asthma in hospitalized and non-hospitalized patients with COVID-19.J Allergy Clin Immunol. 2020.
https://doi.org/10.1016/j.jaci.2020.06.010. [Epub ahead of print].
- Micheletto C, Bilò MB, Antonicelli L, et al.; and on behalf of IRSA.
Severe asthma in adolescents and adults: a national, multicenter
registry in real life. Eur Ann Allergy Clin Immunol .
2018;5:196-201.
- Department of Civil Protection Coronavirus task force, National and
Subregional data repository available on GitHub.
https://github.com/pcm-dpc/COVID-19 Accessed June 10, 2020.
- Peters MC, Sajuthi S, Deford P, et al.; National Heart, Lung, and
Blood Institute Severe Asthma Research Program-3 Investigators.
COVID-19 related genes in sputum cells in asthma: relationship to
demographic features and corticosteroids. Am J Respir Crit Care
Med . 2020. https://doi.org/10.1164/rccm.202003-0821OC”
https://doi.org/10.1164/rccm.202003-0821OC. [Epub ahead of print].
- Carli G, Cecchi L, Stebbing J, Parronchi P, Farsi A. Is asthma
protective against COVID-19? Allergy . 2020.
https://doi.org/10.1111/all.14426” https://doi.org/10.1111/all.14426.
[Epub ahead of print].
- Mahdavinia M, Foster KJ, Jauregui E, et al. Asthma prolongs intubation
in COVID-19. J Allergy Clin Immunol Pract .
2020;S2213-2198(20)30476-1.
https://doi.org/10.1016/j.jaip.2020.05.006”
https://doi.org/10.1016/j.jaip.2020.05.006. In press.
- Davies NG, Klepac P, Liu Y, Prem K, Jit M CMMID COVID-19 working
group; Eggo RM. Age-dependent effects in the transmission and control
of COVID-19 epidemics. Nat Med . 2020.
https://doi.org/10.1038/s41591-020-0962-9.